| Name | Title | Contact Details |
|---|
Immersive virtual events built for the future of hybrid work. Jugo is the world`s first complete virtual meetings and events platform for beautifully immersive experiences.
We build intelligent, innovative technology devices to improve construction jobsite safety and keep projects moving forward. Connecting jobsites. Advancing safety.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Britive Extends Privileged Access Management To Your Multi-Cloud Environments with Just In Time Privileges, Privilege Right Sizing & Secrets Governance
Transforming genetic testing and personalized medicine Our single method approach uses whole genome sequencing (WGS) to look at your entire DNA. It identifies all major types of genetic changes: ATCG Small sequence changes Structural Variants Mitochond...